Blondel; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blondel; Marc.The latest application filed is for "use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction".

Company Profile

1.4.10

Blondel; Marc - Brest FR
Blondel; Marc - Saint Pol de Leon FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hydrazone derivatives for preventing or treating EBV-related cancers Grant 11,406,631 - Blondel , et al. August 9, 2	2022-08-09
Use Of Disulfiram Or Its Derivatives For The Treatment Of Mitochondrial Diseases Or Dysfunction App 20220241223 - PROCACCIO; Vincent ; et al.	2022-08-04
Novel Hydrazone Derivatives For Preventing Or Treating EBV-Related Cancers App 20210161887 - Blondel; Marc ; et al.	2021-06-03
Compounds For The Treatment Of Mitochondrial Diseases App 20120329834 - Blondel; Marc ; et al.	2012-12-27
Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells Grant 8,252,958 - Becq , et al. August 28, 2	2012-08-28
Screening Molecules With Anti-prion Activity: Kits, Methods And Screened Molecules App 20120122916 - BLONDEL; Marc ; et al.	2012-05-17
Screening molecules with anti-prion activity: kits, methods and screened molecules Grant 8,129,402 - Blondel , et al. March 6, 2	2012-03-06
Use of chlorine Guanabenz derivatives for treating prion-based diseases App 20110251428 - Blondel; Marc ; et al.	2011-10-13
Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases Grant 7,932,422 - Bertolotti , et al. April 26, 2	2011-04-26
Screening Molecules With Anti-prion Activity: Kits, Methods And Screened Molecules App 20110092483 - BLONDEL; MARC ; et al.	2011-04-21
Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases App 20100036166 - Bertolotti; Anne ; et al.	2010-02-11
Use of Guanabenz and Its Derivatives for Making Drugs for Treating Cystic Fibrosis and Diseases Related to a Protein Addressing Deficiency in the Cells App 20090306430 - Becq; Frederic ; et al.	2009-12-10
Screening molecules with anti-prion activity: kits, methods and screened molecules App 20070031821 - Blondel; Marc ; et al.	2007-02-08
Screening molecules with anti-prion activity: kits, methods and screened molecules App 20060172337 - Blondel; Marc ; et al.	2006-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.